Neo Zaltan Tablet 5/50 mg
Amlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Mirae Bio Pharmaceutical Co., Ltd.
MFDS item code 201502667 · Approved 2015.04.30
This product's status changed to Expired on 2025.04.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Control of essential hypertension; initial treatment of stage 2 hypertension
This medication is used for patients with essential hypertension who have difficulty controlling blood pressure with monotherapy. It is also used as an initial treatment for patients with stage 2 hypertension who require combination therapy to achieve treatment goals. This helps effectively lower blood pressure and aids in blood pressure management.
The recommended dose is 1 tablet once daily, taken with water, regardless of meals. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. - 5/50 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected extent to which the combination product will achieve the treatment goal compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dosage adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular effective circulating volume: Administration of this medicine is not recommended in a small number of patients with reduced intravascular effective circulating volume (e.g., patients being treated with high doses of diuretics). (See section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: In patients aged 75 years or older, a starting dose of losartan of 25 mg once daily is recommended; therefore, administration of this medicine as initial therapy is not recommended.
○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its administration is not recommended.
This drug can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. This drug may cause hypotension when initially administered to patients with reduced intravascular blood volume; thus, those with symptoms should receive treatment first. It is contraindicated in patients with allergies to the main ingredient or similar medications, pregnant or breastfeeding women, severe liver dysfunction, severe aortic stenosis, or those in a state of shock. Caution is necessary in patients with reduced blood volume, strict salt restriction, or moderate to severe renal impairment. Side effects such as dizziness, headache, drowsiness, edema, dyspepsia, skin rash, palpitations, and orthostatic hypotension may occur, so caution is advised. Particularly, dizziness may occur during hypertension treatment, so it is advisable to avoid driving or operating dangerous machinery. Patients with impaired liver or kidney function should consult with a physician before taking this drug, and caution is required when taken with potassium-sparing diuretics or potassium supplements, as potassium levels may rise. When combined with other antihypertensive drugs, the blood pressure-lowering effect may increase, so follow a doctor's instructions. This drug is not recommended for children or elderly patients over 75 years of age. In case of overdose, severe hypotension and tachycardia may occur; thus, seek medical attention immediately, and treatment should be given based on symptoms. Store this medication out of reach of children and do not transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. Additionally, it is best stored at room temperature between 1 to 30 degrees Celsius. This helps maintain the efficacy of the drug and ensures safe use.
White rectangular film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Amlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Mirae Bio Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
Huwons Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
CombinationAmlodipine Besylate 13.888mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.